卷 31, 编号 4 (December 2016): 《眼科学报》

Editorial

27-gauge vitrectomy—an update on recent surgical outcomes
DanielSu, Jean-PierreHubschman
Individualized treatment with aflibercept in age-related macular degeneration patients with early persistent retinal fluid
AlfredoGarcía-Layana, ManuelSaenz-de-Viteri
What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema? Review of the 2-year results of Diabetic Retinopathy Clinical Research Network Protocol T
MichalSchaap-Fogler, RitaEhrlich
Reaching for the brain: stimulating neural activity as the big leap in optic nerve regeneration
EmielGeeraerts, LieveMoons, LiesDe Groef
Comment on retinal ganglion cell electrical activity, mammalian target of rapamycin signaling and optic nerve regeneration
Louise A.Mesentier-Louro, RosaliaMendez-Otero
In vitro eye embryogenesis from induced pluripotent stem cells for ocular surface disease treatment
MatthiasFuest, Jodhbir S.Mehta
Central nervous system: re-establishing lost connections
SteffiDaniel, Abbot F.Clark, Colleen M.McDowell
Patient-centered outcomes in treatment options for proliferative diabetic retinopathy
Nicolas A.Yannuzz, William E.Smiddy
Optical coherence tomography angiography of non-exudative choroidal neovascularization
LeeKiang, Steven T.Bailey, YaliJia, DavidHuang